Homologous genetic recombination occurs during the life cycle of virtually every organism Genetic studies especially in prokaryotes and fungi have defined the rules of recombination, led to the characterization of alternate pathways and to the development of molecular models The biochemistry of homologous genetic recombination has advanced most productively in bacteria and fungi due to the extensive genetic understanding of these organisms The identification of mutants defective in homologous recombination, purification and characterization of the gene products that participate in recombination has brought the ultimate goal of reconstituting a cell-k free system for Eschenchia coli, at least with naked DNA substrates, closer to reality.

In this study, the benzaldehyde lyase (BAL, EC 4.1.2.38) production in E. coli BL21 (DE3) pLySs as intracellular and in Bacillus species as extracellular were investigated, and comparison of the production capacity of the enzyme in the developed recombinant microorganisms were compared. For this purpose, firstly, PCR amplified bal gene was cloned into pRSETA vector which is under the control of strong T7 promoter and expressed in E. coli BL21 (DE3) pLysS strain. With developed recombinant E. coli BL21 (DE3) pLySs cells, the effect of bioprocess parameters was systematically investigated. Among the investigated media, the highest cell concentration and benzaldehyde lyase activity were obtained as 2.0 kg m-3 and 1060 U cm-3, respectively, in the medium containing 20.0 kg m-3 glucose, 11.8 kg m-3 (NH4)2HPO4 and the salt solution. Thereafter, oxygen transfer effects on benzaldehyde lyase production were investigated at air inlet v rate of QO/VR = 0.5 vvm, and agitation rates of N=500 and 750 min-1 and at QO/VR = 0.7 vvm, N=750 min-1 in pilot scale bioreactor and the highest cell concentration and volumetric BAL activity were found as 1.7 kg m-3 and 990 U cm-3, respectively, at 0.5 vvm, 750 min-1 condition. Next, the signal DNA sequence of serine alkaline protease (SAP) from B. licheniformis DSM 1969 chromosomal DNA (pre-subC) was fused in front of the bal by using PCR-based gene splicing by overlap extension (SOE) method. The fusion product of hybrid gene first cloned into pUC19 plasmid, thereafter sub-cloned into pBR374 shuttle vector and recombinant plasmid was transferred into various Bacillus species. However, no extracellular production of benzaldehyde lyase was observed in none of the developed recombinant Bacillus species, probably because of ineffective secretion system, inefficient folding of heterologous protein, degradation of enzyme due to proteolytic activity or high inactivation rate of the enzyme.

Diss. (sammanfattning) Stockholm : Karol inst., 2003. / Härtill 4 uppsatser.

Thesis (Ph. D.)--University of Virginia, 2007. / Title from title page. Includes bibliographical references. Also available online through Digital Dissertations.

Thesis (Ph. D.)--Carleton University, 1999. / Also available in electronic format on the Internet.

Thesis (Ph.D.)--Baylor University, 2009. / Includes bibliographical references (p. 172-194).

O P. vivax é a segunda espécie mais prevalente causadora de malária no mundo. Medidas de controle ineficientes exigem o desenvolvimento de novas estratégias de prevenção, como vacinas, novas drogas e novos inseticidas. O objetivo geral do trabalho foi gerar uma formulação vacinal universal com proteínas e adenovírus recombinantes capazes de induzir anticorpos contra as diferentes formas alélicas da proteína circumsporozoíta (CSP) do P. vivax. As proteínas foram produzidas em E. coli e purificadas por cromatografia de afinidade e troca iônica. A obtenção destas proteínas nos permitiu testar qual seria a melhor formulação vacinal para a indução de anticorpos contra as três formas alélicas da proteína CSP de P. vivax (PvCSP). Anticorpos específicos reconheceram esporozoítas do P. vivax por imunofluorescência. Por fim testamos o uso de dois adenovírus recombinantes, um símio e um humano, deficientes em replicação, expressando as três regiões imunodominantes da proteína PvCSP em fusão. Estes foram capazes de induzir resposta imune específica contra as proteínas PvCSP sendo testados em esquema de prime-boost heterólogo, onde camundongos foram primados com os adenovírus e nas doses-reforço receberam a mistura com as três proteínas recombinantes. / The Plasmodium vivax is the second most prevalent species of malaria in the world. Inefficient measures of control used today demand the development of new strategies for prevention, as vaccines, new drugs and new insecticides. The central objective of this thesis was to generate a universal vaccine formulation with proteins and recombinant adenoviral vectors representing the different allelic forms of the circumsporozoite protein (CSP) of the P. vivax. The recombinant proteins were expressed in E. coli and purified. These proteins allowed us to test which would be the best vaccine formulation for the induction of antibodies against the three allelic forms of CSP. The specific antibodies also recognized P. vivax sporozoites by immunofluorescence. Finally we test the use of two recombinant adenoviral vectors, a simian and a human, both replication deficient, expressing a protein containing the repeat regions of the CSP in fusion. These adenoviral vectors induced specific immune response against CSP and were successfully used in an immunization regimen of heterologous prime and boost where in the first dose the mice received recombinant adenoviral vector and in the subsequent doses, the mixture with three recombinant proteins.

Thesis (D.P.H.)--University of Michigan.

Dissertation (D.P.H.)--University of Michigan.

Made available in DSpace on 2014-12-17T15:01:21Z (GMT). No. of bitstreams: 1 RobertaVAC_DISSERT.pdf: 2111666 bytes, checksum: 5b317150d6db63bae04e852173ace9d2 (MD5) Previous issue date: 2009-12-14 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Visceral leishmaniosis caused by Leishmania chagasi, also known as calazar, presented, in the period from 1990 to 2005, tax of incidence in Brazil varying between 1 and 3 cases for 100 000 inhabitants. The Northeast region that up to the year of 2000 contributed with almost 90% of the registered cases is reducing his participation in the current decade, reaching 56% in 2005. Conventional leishmaniasis treatment is costly and it shows high toxicity, demanding more research for alternative treatments, with special interest in development of vaccines and diagnosis kits which include production of recombinant antigens by host cells. Escherichia coli has been the microorganism most studied and used as a host for recombinant protein production. Therefore, the aim of this work was to study the influence of induction on cellular growth and to verify the type of Leishmania chagasi antigens expression (intra or extracellular) during two recombinant E. coli clones (kmp11 and P36) cultivation in rotary incubator (shaker) using three different media (2xTY, TB, FASS+EL). For that, tests were carried out using conditions established in the literature for E. coli (37?C and 200 rpm) and media supplemented with antibiotics to guarantee that only competent cells grows. First, tests were carried out without induction in order to verify the two microorganisms kinetic behavior (growth and substrate consumption) in different media. Next, the induction was carried out through the addition of IPTG (1mM as final concentration), at the first hour of cultivation. It was observed that protein expression were intracellular for all clones and media tested, however the highest level of expression was clearly observed by the electrophoresis band density (intensity) for 2xTY medium and kmp11 protein. Although it contains the lowest substrate concentration, consequently, a reduced cellular concentration when compared to other media, it appeared that this medium and clone combination is the most indicated for recombinant protein production. Therefore, the objective of this work was achieved, since the interested proteins were produced. Consequently, this result motivates new studies for production optimization using different cultivation strategies / A leishmaniose visceral, causada pela esp?cie Leishmania chagasi, tamb?m conhecida como calazar, apresentou, no per?odo de 1990 a 2005, taxa de incid?ncia no Brasil variando entre 1 e 3 casos por 100 mil habitantes. A regi?o Nordeste, que at? o ano de 2000 contribuiu com quase 90% dos casos registrados, est? reduzindo sua participa??o na d?cada atual, chegando a 56% em 2005. O alto custo e toxicidade das drogas usadas no tratamento convencional dessa leishmaniose levaram a busca de tratamentos alternativos, com interesse especial na pesquisa e produ??o de ant?genos por microrganismos recombinantes para desenvolvimento de vacinas e kits de diagn?stico. A bact?ria Escherichia coli tem sido o microrganismo mais estudado e usado como hospedeiro para produ??o de prote?nas recombinantes. Nesse contexto, este trabalho tem como objetivo estudar a influ?ncia da indu??o no crescimento celular e a verifica??o do tipo de express?o (intra ou extracelular) de ant?genos de Leishmania chagasi atrav?s de cultivo de dois clones de E. coli recombinante (kmp11 e P36) em incubador rotativo (shaker) usando tr?s meios diferentes (2xTY, TB, FASS+EL). Para isso, foram realizados ensaios em condi??es estabelecidas na literatura para E. coli (37?C ? 200 rpm) e os meios suplementados com antibi?ticos para garantir somente o crescimento de c?lulas competentes. Na primeira etapa, foram realizados ensaios sem indu??o a fim de se verificar o comportamento cin?tico dos dois clones (crescimento e consumo de substrato) nos diferentes meios. Na segunda etapa, a indu??o foi realizada atrav?s da adi??o de IPTG (concentra??o final de 1mM), na primeira hora de cultivo. Foi observada que a express?o das prote?nas foi intracelular para todos os clones e meios testados, entretanto o maior n?vel foi verificado nitidamente pela densidade (intensidade) da banda nos g?is de eletroforese para o meio 2xTY e prote?na kmp11. Apesar de o meio 2xTY conter uma menor concentra??o de substratos, conseq?entemente, uma concentra??o celular reduzida quando comparada aos outros meios, pareceu que esta combina??o de meio e clone ? mais indicada para produ??o das prote?nas recombinantes testadas neste trabalho. O objetivo desse trabalho foi alcan?ado j? que a prote?na de interesse foi produzida. Conseq?entemente, este resultado motiva novos estudos para otimiza??o da produ??o usando diferentes estrat?gias de cultivo